Filter
2304
Filtered Results: 2304
Text search:
controlled
drugs
Featured
Recommendations
264
New Publications
513
Language
Document type
No document type
1341
Guidelines
400
Studies & Reports
312
Manuals
117
Strategic & Response Plan
62
Fact sheets
32
Training Material
26
Situation Updates
6
Brochures
4
Resource Platforms
2
Infographics
2
Countries / Regions
India
171
Kenya
65
Global
63
South Africa
56
Western and Central Europe
46
Uganda
43
Ethiopia
40
Nigeria
38
Tanzania
34
Sierra Leone
33
Latin America and the Carribbean
32
Africa
31
Zambia
30
Nepal
29
Malawi
28
Ukraine
28
Ghana
26
Eastern Europe
26
Liberia
23
Rwanda
23
Philippines
22
Myanmar / Burma
22
Zimbabwe
20
Bangladesh
19
Colombia
17
Russia
17
Brazil
16
Syria
15
Indonesia
15
South–East Asia Region
15
Lesotho
14
Asia
13
South Sudan
12
Mozambique
11
Namibia
11
Eswatini/ Swaziland
11
Burkina Faso
10
Senegal
9
Argentina
9
Congo, Democratic Republic of
8
Botswana
8
Guinea
7
Cameroon
7
Germany
7
East and Southern Africa
7
Paraguay
7
Venezuela
7
Afghanistan
6
Yemen
6
Haiti
5
Lebanon
5
Thailand
5
Sudan
5
Bolivia
5
Eastern Europe and Central Asia
5
Tajikistan
5
Mali
4
USA
4
Iraq
4
Jordan
4
Chile
4
West and Central Africa
4
Middle East and North Africa
4
North America
4
Somalia
3
Pakistan
3
Cambodia
3
Central African Republic
3
Peru
3
Angola
3
Madagascar
3
Moldova
3
Iran
3
Georgia
3
Guinea-Bissau
2
Morocco
2
Saudi Arabia
2
Egypt
2
China
2
Benin
2
North Macedonia
2
Hungary
2
Ecuador
2
Libya
2
Mexico
2
Bhutan
2
Palestine
2
Albania
2
Laos
2
Canada
2
Lithuania
2
Kyrgyzstan
2
Vietnam
2
Jamaica
2
Côte d’Ivoire / Ivory Coast
1
Turkey
1
Singapore
1
Papua New Guinea
1
Serbia
1
Burundi
1
Greece
1
Sri Lanka
1
Western Pacific Region
1
Poland
1
Djibouti
1
Armenia
1
Timor Leste/ East Timor
1
Qatar
1
Romania
1
Australia
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
819
Clinical Guidelines
321
Public Health
156
Women & Child Health
105
Key Resources
55
Pharmacy & Technologies
29
Capacity Building
26
Protection & Security
1
Toolboxes
Mental Health
292
HIV
222
TB
205
COVID-19
113
AMR
90
Pharmacy
88
NCDs
87
NTDs
67
Caregiver
57
Rapid Response
49
Ebola
45
Conflict
35
Refugee
26
Disability
22
Planetary Health
21
Cholera
14
Global Health Education
14
Natural Hazards
13
Polio
10
Specific Hazards
6
Health Financing Toolbox
6
Zika
5
Social Ethics
2
Here you can download brochures, posters and leaflets for the prevention of drug use and treatment, care and rehabilitation programmes
Accessed: 29.09.2019
Для создания этого отчета MSF исследовала программы и практику лечения лекарственно-чувствительного и лекарственно-устойчивого туберкулеза в восьмистранах с высо...
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an...
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market for cocaine, starting with a review of cocaine supply...
This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing thirty key questions about PrEP and how it might be implemented in the UK.
Johnson CC et al. Journal of the International AIDS Society 2017, 20:21594 http://www.jiasociety.org/index.php/jias/article/view/21594 | https://doi.org/10.7448/IAS.20.1.21594
Public health criteria to adjust public health and social measures in the context of COVID-19
recommended
In response to COVID-19, countries around the globe have implemented several public health and social measures (PHSM), including large scale measures such as movement restrictions, closure of schools and businesses, geographical area quarantine, and international travel restrictions.
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
COVID-19 is a serious disease and all people living with HIV should take all recommended preventive measures to minimize exposure to, and prevent infection by, the virus that causes COVID-19. As in the general population, older people living with HIV or people living with HIV with heart or lung prob...
In emergency or humanitarian settings, mobile clinics are used to bring essential lifesaving health care to communities affected by crises. Though there are standard emergency benefit packages for health services during emergencies, there are however no agreed or standard way of running mobile clini...
Factors to take into account when choosing, reviewing and changing medicines.
Rescue therapy:
For symptomatic hyperglycaemia, consider insulin or a sulfonylurea and review when blood glucose control has been achieved.
Diet and lifestyle advice:
At each point reinforce advice about diet and life...
Standard treatment guidelines
recommended
F.No. INDO/FRC/442/2008-IHD | INDIAN COUNCIL OF MEDICAL RESEARCH
| New Delhi, the 1st July, 2014 | OFFICE MEMORANDUM
Policy Brief
Accessed: 20.11.2019
